(19)
(11) EP 0 901 464 A1

(12)

(43) Date of publication:
17.03.1999 Bulletin 1999/11

(21) Application number: 97923088.0

(22) Date of filing: 07.05.1997
(51) International Patent Classification (IPC): 
A61K 31/ 165( . )
A61P 29/ 00( . )
A61P 37/ 08( . )
C07C 323/ 60( . )
A61K 31/ 00( . )
A61P 37/ 00( . )
A61P 43/ 00( . )
(86) International application number:
PCT/EP1997/002500
(87) International publication number:
WO 1997/043250 (20.11.1997 Gazette 1997/50)
(84) Designated Contracting States:
BE CH DE ES FR GB IT LI NL

(30) Priority: 10.05.1996 GB 19960009795

(71) Applicant: SMITHKLINE BEECHAM PLC
Brentford, Middlesex TW8 9EP (GB)

(72) Inventors:
  • SMITH, David, Glynn, SmithKline Beecham
    Harlow, Essex CM19 5AW (GB)
  • BAILEY, Stuart, SmithKline Beecham
    Harlow, Essex CM19 5AW (GB)
  • FALLER, Andrew, SmithKline Beecham
    Harlow, Essex CM19 5AW (GB)
  • BUCKLE, Derek, Richard, SmithKline Beecham
    Harlow, Essex CM19 5AW (GB)

(74) Representative: West, Vivien, et al 
SmithKline Beecham plc Corporate Intellectual Property, Two New Horizons Court
Brentford, Middlesex TW8 9EP
Brentford, Middlesex TW8 9EP (GB)

   


(54) HYDROXAMIC ACID BASED INHIBITORS OF THE FORMATION OF CD23 AND TNF